Cart
sales@molnova.com
Home - Products - Others - Other Targets - Glutaminase-IN-3

Glutaminase-IN-3

CAS No. 1439399-45-7

Glutaminase-IN-3( —— )

Catalog No. M34941 CAS No. 1439399-45-7

Glutaminase-IN-3 is a potent Glutaminase 1 inhibitor with potential antitumor activity and inhibits GLS1 for cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 54 Get Quote
10MG 77 Get Quote
25MG 118 Get Quote
50MG 174 Get Quote
100MG 251 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Glutaminase-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    Glutaminase-IN-3 is a potent Glutaminase 1 inhibitor with potential antitumor activity and inhibits GLS1 for cancer research.
  • Description
    Glutaminase-IN-3 (compound 657) is a potent glutaminase inhibitor with an IC50 of 0.24 μM for Glutaminase 1 (GLS1). Glutaminase-IN-3 is extracted from patent WO2014089048A1, compound 657.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Glutaminase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1439399-45-7
  • Formula Weight
    452.45
  • Molecular Formula
    C19H19F3N6O2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (110.51 mM; Ultrasonic )
  • SMILES
    FC(F)(F)Oc1cccc(CC(=O)N=c2ccc(CCCCc3n[nH]c(=N)s3)n[nH]2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mark K. Bennett, et al. Treatment of cancer with heterocyclic inhibitors of glutaminase. WO2014089048A1.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Benzeneboronic acid

    Benzeneboronic acid is a boronic acid that is used in Mizoroki-Heck and Suzuki-Miyaura coupling reactions.

  • Glofitamab

    Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.

  • Fibrinopeptide A, hu...

    Fibrinopeptide A, human is a 16-residue short polypeptide cleaved from fibrinogen by thrombin. Fibrinopeptide A, human locates at the NH2-termini of the Aα chain.The conversion of monomeric fibrinogen into polymeric fibrin is mediated by thrombin, which binds to the central region of fibrinogen and catalyzes cleavage of the 2 short peptides, the 16-residue fibrinopeptide A (FpA) and the 14-residue fibrinopeptide B (FpB), located at the NH2-termini of the Aα and Bβ chains, respectively.

Sign In Join Free